The raas in heart failure: An update on clinical trials and opportunities for therapy

C. Tissa Kappagoda, Ezra A Amsterdam

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Heart failure continues to be a significant health problem worldwide. Despite significant progress in our understanding of the pathophysiology of the condition, its medical management remains a challenge, with a significant 5-year mortality. At the present time, treatment of heart failure has centered on the idea that its clinical manifestations are associated with a derangement of the renin-angiotensin-aldosterone system (RAAS) leading eventually to retention of salt and water. However, the RAAS is no longer viewed as a single endocrine system operating through blood-borne humoral agents but as a more complex system involving a variety of cell types which influence the functions of the cardiovascular system in health and disease. The latter effects, particularly those involving the actions of nitric oxide and endothelial cell function, may open new options for therapy in the future.

Original languageEnglish (US)
Title of host publicationAging and Heart Failure: Mechanisms and Management
PublisherSpringer New York
Pages165-182
Number of pages18
ISBN (Electronic)9781493902682
ISBN (Print)9781493902675
DOIs
StatePublished - Jan 1 2014

Fingerprint

Renin-Angiotensin System
Heart Failure
Clinical Trials
Endocrine System
Cardiovascular System
Treatment Failure
Nitric Oxide
Endothelial Cells
Salts
Mortality
Water
Health
Therapeutics
Global Health

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Kappagoda, C. T., & Amsterdam, E. A. (2014). The raas in heart failure: An update on clinical trials and opportunities for therapy. In Aging and Heart Failure: Mechanisms and Management (pp. 165-182). Springer New York. https://doi.org/10.1007/978-1-4939-0268-2_12

The raas in heart failure : An update on clinical trials and opportunities for therapy. / Kappagoda, C. Tissa; Amsterdam, Ezra A.

Aging and Heart Failure: Mechanisms and Management. Springer New York, 2014. p. 165-182.

Research output: Chapter in Book/Report/Conference proceedingChapter

Kappagoda, CT & Amsterdam, EA 2014, The raas in heart failure: An update on clinical trials and opportunities for therapy. in Aging and Heart Failure: Mechanisms and Management. Springer New York, pp. 165-182. https://doi.org/10.1007/978-1-4939-0268-2_12
Kappagoda CT, Amsterdam EA. The raas in heart failure: An update on clinical trials and opportunities for therapy. In Aging and Heart Failure: Mechanisms and Management. Springer New York. 2014. p. 165-182 https://doi.org/10.1007/978-1-4939-0268-2_12
Kappagoda, C. Tissa ; Amsterdam, Ezra A. / The raas in heart failure : An update on clinical trials and opportunities for therapy. Aging and Heart Failure: Mechanisms and Management. Springer New York, 2014. pp. 165-182
@inbook{2cb3394370584023b783764d8fd292cb,
title = "The raas in heart failure: An update on clinical trials and opportunities for therapy",
abstract = "Heart failure continues to be a significant health problem worldwide. Despite significant progress in our understanding of the pathophysiology of the condition, its medical management remains a challenge, with a significant 5-year mortality. At the present time, treatment of heart failure has centered on the idea that its clinical manifestations are associated with a derangement of the renin-angiotensin-aldosterone system (RAAS) leading eventually to retention of salt and water. However, the RAAS is no longer viewed as a single endocrine system operating through blood-borne humoral agents but as a more complex system involving a variety of cell types which influence the functions of the cardiovascular system in health and disease. The latter effects, particularly those involving the actions of nitric oxide and endothelial cell function, may open new options for therapy in the future.",
author = "Kappagoda, {C. Tissa} and Amsterdam, {Ezra A}",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/978-1-4939-0268-2_12",
language = "English (US)",
isbn = "9781493902675",
pages = "165--182",
booktitle = "Aging and Heart Failure: Mechanisms and Management",
publisher = "Springer New York",

}

TY - CHAP

T1 - The raas in heart failure

T2 - An update on clinical trials and opportunities for therapy

AU - Kappagoda, C. Tissa

AU - Amsterdam, Ezra A

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Heart failure continues to be a significant health problem worldwide. Despite significant progress in our understanding of the pathophysiology of the condition, its medical management remains a challenge, with a significant 5-year mortality. At the present time, treatment of heart failure has centered on the idea that its clinical manifestations are associated with a derangement of the renin-angiotensin-aldosterone system (RAAS) leading eventually to retention of salt and water. However, the RAAS is no longer viewed as a single endocrine system operating through blood-borne humoral agents but as a more complex system involving a variety of cell types which influence the functions of the cardiovascular system in health and disease. The latter effects, particularly those involving the actions of nitric oxide and endothelial cell function, may open new options for therapy in the future.

AB - Heart failure continues to be a significant health problem worldwide. Despite significant progress in our understanding of the pathophysiology of the condition, its medical management remains a challenge, with a significant 5-year mortality. At the present time, treatment of heart failure has centered on the idea that its clinical manifestations are associated with a derangement of the renin-angiotensin-aldosterone system (RAAS) leading eventually to retention of salt and water. However, the RAAS is no longer viewed as a single endocrine system operating through blood-borne humoral agents but as a more complex system involving a variety of cell types which influence the functions of the cardiovascular system in health and disease. The latter effects, particularly those involving the actions of nitric oxide and endothelial cell function, may open new options for therapy in the future.

UR - http://www.scopus.com/inward/record.url?scp=84960413257&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960413257&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-0268-2_12

DO - 10.1007/978-1-4939-0268-2_12

M3 - Chapter

AN - SCOPUS:84960413257

SN - 9781493902675

SP - 165

EP - 182

BT - Aging and Heart Failure: Mechanisms and Management

PB - Springer New York

ER -